|
US2003199A
(en)
|
1930-05-31 |
1935-05-28 |
Johnson Frank James |
Automatic coal stoker
|
|
US2003149A
(en)
|
1931-05-22 |
1935-05-28 |
Autographic Register Co |
Manifolding
|
|
US2003065A
(en)
|
1931-06-20 |
1935-05-28 |
John R Ditmars |
Composition for coating sheets, fibrous stocks, and the like
|
|
US2004102A
(en)
|
1932-02-24 |
1935-06-11 |
Daniel A Dickey |
Hollow steel propeller construction
|
|
US2004138A
(en)
|
1932-11-30 |
1935-06-11 |
Byers A M Co |
Method of making wrought iron pipe
|
|
US2002165A
(en)
|
1933-07-08 |
1935-05-21 |
Charles A Winslow |
Air cleaner
|
|
US2003187A
(en)
|
1933-10-02 |
1935-05-28 |
Frederick H Shaw |
Automobile radio device
|
|
US2003166A
(en)
|
1933-10-26 |
1935-05-28 |
Zancan Ottavio |
Front drive for motor cars
|
|
US2001051A
(en)
|
1933-12-01 |
1935-05-14 |
Angelina Mariani |
Tamperproof meter box with cutout control and fuse drawer for electric meters
|
|
US2004092A
(en)
|
1933-12-15 |
1935-06-11 |
John L Chaney |
Device for indicating the temperature of liquids
|
|
US2003060A
(en)
|
1934-04-02 |
1935-05-28 |
Ernest L Heckert |
Thermostatic controlling device
|
|
US2667486A
(en)
|
1951-05-24 |
1954-01-26 |
Research Corp |
2,4-diamino pteridine and derivatives
|
|
IL44058A
(en)
|
1973-02-02 |
1978-10-31 |
Ciba Geigy Ag |
3amino-1,2,4-benzotriazine 1,4-di-noxide derivatives, their preparation and compositions for the control of microorganisms containing them
|
|
AU535258B2
(en)
|
1979-08-31 |
1984-03-08 |
Ici Australia Limited |
Benzotriazines
|
|
DE3205638A1
(de)
|
1982-02-17 |
1983-08-25 |
Hoechst Ag, 6230 Frankfurt |
Trisubstituierte pyrimidin-5-carbonsaeuren und deren derivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
|
|
US4490289A
(en)
|
1982-09-16 |
1984-12-25 |
Hoffmann-La Roche Inc. |
Homogeneous human interleukin 2
|
|
US5624925A
(en)
|
1986-09-25 |
1997-04-29 |
Sri International |
1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
|
|
JP2598100B2
(ja)
|
1988-08-31 |
1997-04-09 |
キヤノン株式会社 |
電子写真感光体
|
|
US5214059A
(en)
|
1989-07-03 |
1993-05-25 |
Hoechst-Roussel Pharmaceuticals Incorporated |
2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders
|
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
|
US5776502A
(en)
|
1989-07-18 |
1998-07-07 |
Oncogene Science, Inc. |
Methods of transcriptionally modulating gene expression
|
|
US5041430A
(en)
|
1989-09-18 |
1991-08-20 |
Du Pont Mereck Pharmaceutical Company |
Oral anticoagulant/platelet inhibitor low dose formulation
|
|
JPH03127790A
(ja)
|
1989-10-11 |
1991-05-30 |
Morishita Pharmaceut Co Ltd |
Ｎ―（１ｈ―テトラゾール―５―イル）―２―アニリノ―５―ピリミジンカルボキシアミド類及びその合成中間体
|
|
GB9003553D0
(en)
|
1990-02-16 |
1990-04-11 |
Ici Plc |
Herbicidal compositions
|
|
JP2839106B2
(ja)
|
1990-02-19 |
1998-12-16 |
キヤノン株式会社 |
電子写真感光体
|
|
GB9012592D0
(en)
|
1990-06-06 |
1990-07-25 |
Smithkline Beecham Intercredit |
Compounds
|
|
FR2665159B1
(fr)
|
1990-07-24 |
1992-11-13 |
Rhone Poulenc Sante |
Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
|
IE74711B1
(en)
|
1990-07-27 |
1997-07-30 |
Ici Plc |
Fungicides
|
|
GB9016800D0
(en)
|
1990-07-31 |
1990-09-12 |
Shell Int Research |
Tetrahydropyrimidine derivatives
|
|
DE4025891A1
(de)
|
1990-08-16 |
1992-02-20 |
Bayer Ag |
Pyrimidyl-substituierte acrylsaeureester
|
|
JPH05345780A
(ja)
|
1991-12-24 |
1993-12-27 |
Kumiai Chem Ind Co Ltd |
ピリミジンまたはトリアジン誘導体及び除草剤
|
|
HUT63941A
(en)
|
1992-05-15 |
1993-11-29 |
Hoechst Ag |
Process for producing 4-alkyl-substituted pyrimidine-5-carboxanilide derivatives, and fungicidal compositions comprising same
|
|
US5438130A
(en)
|
1993-01-15 |
1995-08-01 |
Cambridge Neuroscience, Inc. |
Fucosylated guanosine disulfates as excitatory amino acid antagonists
|
|
JPH0741461A
(ja)
|
1993-05-27 |
1995-02-10 |
Eisai Co Ltd |
スルホン酸エステル誘導体
|
|
JPH0782183A
(ja)
|
1993-09-09 |
1995-03-28 |
Canon Inc |
液晶中間体化合物、液晶性化合物、高分子液晶化合物、高分子液晶共重合体化合物、それらの組成物、液晶素子および記録装置
|
|
DE4338704A1
(de)
|
1993-11-12 |
1995-05-18 |
Hoechst Ag |
Stabilisierte Oligonucleotide und deren Verwendung
|
|
US5530000A
(en)
|
1993-12-22 |
1996-06-25 |
Ortho Pharmaceutical Corporation |
Substituted pyrimidinylaminothiazole derivatives useful as platelet aggreggation inhibitors
|
|
GB9506466D0
(en)
|
1994-08-26 |
1995-05-17 |
Prolifix Ltd |
Cell cycle regulated repressor and dna element
|
|
US5597826A
(en)
|
1994-09-14 |
1997-01-28 |
Pfizer Inc. |
Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
|
|
DE19502912A1
(de)
|
1995-01-31 |
1996-08-01 |
Hoechst Ag |
G-Cap Stabilisierte Oligonucleotide
|
|
US6326487B1
(en)
|
1995-06-05 |
2001-12-04 |
Aventis Pharma Deutschland Gmbh |
3 modified oligonucleotide derivatives
|
|
CA2230894A1
(en)
|
1995-09-01 |
1997-03-13 |
Signal Pharmaceuticals, Inc. |
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
EP0895475A4
(en)
|
1995-12-29 |
2000-08-23 |
Smithkline Beecham Corp |
VITRONECTIN RECEPTOR ANTAGONISTS
|
|
JPH09274290A
(ja)
|
1996-02-07 |
1997-10-21 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料用の現像液および処理方法
|
|
US6204260B1
(en)
|
1996-02-23 |
2001-03-20 |
Eli Lilly And Company |
Non-peptidyl vasopressin V1a antagonists
|
|
DE59707681D1
(de)
|
1996-10-28 |
2002-08-14 |
Rolic Ag Zug |
Vernetzbare, photoaktive Silanderivate
|
|
DE69737107T2
(de)
|
1996-11-20 |
2007-07-12 |
Introgen Therapeutics Inc., Austin |
Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
|
|
JP3734903B2
(ja)
|
1996-11-21 |
2006-01-11 |
富士写真フイルム株式会社 |
現像処理方法
|
|
JPH10153838A
(ja)
|
1996-11-22 |
1998-06-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JP3720931B2
(ja)
|
1996-11-26 |
2005-11-30 |
富士写真フイルム株式会社 |
ハロゲン化銀写真感光材料の処理方法
|
|
CN1240010A
(zh)
|
1996-12-04 |
1999-12-29 |
金伯利-克拉克环球有限公司 |
湿强度纸的制备方法
|
|
US5935383A
(en)
|
1996-12-04 |
1999-08-10 |
Kimberly-Clark Worldwide, Inc. |
Method for improved wet strength paper
|
|
ES2196396T3
(es)
|
1996-12-23 |
2003-12-16 |
Bristol Myers Squibb Pharma Co |
Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
|
|
JPH10207019A
(ja)
|
1997-01-22 |
1998-08-07 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JPH10213820A
(ja)
|
1997-01-31 |
1998-08-11 |
Canon Inc |
液晶素子及び液晶装置
|
|
DE59807348D1
(de)
|
1997-02-05 |
2003-04-10 |
Rolic Ag Zug |
Photovernetzbare Silanderivate
|
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
JPH10260512A
(ja)
|
1997-03-19 |
1998-09-29 |
Fuji Photo Film Co Ltd |
ハロゲン化銀感光材料の処理方法
|
|
JPH10310583A
(ja)
|
1997-05-09 |
1998-11-24 |
Mitsubishi Chem Corp |
ピリドンアゾ系化合物、感熱転写用色素およびそれを使用した感熱転写材料
|
|
US6070126A
(en)
|
1997-06-13 |
2000-05-30 |
William J. Kokolus |
Immunobiologically-active linear peptides and method of identification
|
|
TW436485B
(en)
|
1997-08-01 |
2001-05-28 |
American Cyanamid Co |
Substituted quinazoline derivatives
|
|
US6635626B1
(en)
|
1997-08-25 |
2003-10-21 |
Bristol-Myers Squibb Co. |
Imidazoquinoxaline protein tyrosine kinase inhibitors
|
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
EP1054004B1
(en)
|
1997-12-15 |
2008-07-16 |
Astellas Pharma Inc. |
Novel pyrimidine-5-carboxamide derivatives
|
|
IL136637A0
(en)
|
1997-12-22 |
2001-06-14 |
Du Pont Pharm Co |
Nitrogen containing heteroaromatics with ortho-substituted pi's as factor xa inhibitors
|
|
KR20010041015A
(ko)
|
1998-02-17 |
2001-05-15 |
윌리엄 제이. 리플린 |
항바이러스성 피리미딘 유도체
|
|
KR100643419B1
(ko)
|
1998-03-27 |
2006-11-10 |
얀센 파마슈티카 엔.브이. |
Ｈｉｖ를 억제하는 피리미딘 유도체
|
|
ES2193660T3
(es)
|
1998-03-27 |
2003-11-01 |
Janssen Pharmaceutica Nv |
Derivados de pirimidina inhibidores de vih.
|
|
US6685938B1
(en)
|
1998-05-29 |
2004-02-03 |
The Scripps Research Institute |
Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases
|
|
DE19830181C1
(de)
|
1998-07-06 |
1999-09-30 |
Inter Control Koehler Hermann |
Mehrpolige elektrische Steckverbindung
|
|
US6136971A
(en)
|
1998-07-17 |
2000-10-24 |
Roche Colorado Corporation |
Preparation of sulfonamides
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
US6288082B1
(en)
|
1998-09-29 |
2001-09-11 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
|
US6297258B1
(en)
|
1998-09-29 |
2001-10-02 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
|
KR100736502B1
(ko)
|
1998-09-29 |
2007-07-06 |
와이어쓰 홀딩스 코포레이션 |
단백질 티로신 키나제 억제제로서 치환된 3-시아노퀴놀린
|
|
EA004436B1
(ru)
|
1998-09-29 |
2004-04-29 |
Уайт Холдингз Корпорейшн |
Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
|
|
EP1058549A4
(en)
|
1998-12-23 |
2003-11-12 |
Bristol Myers Squibb Pharma Co |
FACTOR Xa OR THROMBIN INHIBITORS
|
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
WO2000046203A2
(en)
|
1999-02-04 |
2000-08-10 |
Millennium Pharmaceuticals, Inc. |
G-protein coupled heptahelical receptor binding compounds and methods of use thereof
|
|
EP2308833A3
(en)
|
1999-04-15 |
2011-09-28 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
NZ514576A
(en)
|
1999-04-21 |
2004-02-27 |
Wyeth Corp |
Substituted 3-cyano-[1.7], [1.5], and [1.8]- naphthyridine inhibitors of tyrosine kinases
|
|
AU5020400A
(en)
|
1999-05-20 |
2000-12-12 |
E.I. Du Pont De Nemours And Company |
Heteroaryloxypyrimidine insecticides and acaricides
|
|
US6710221B1
(en)
|
1999-06-15 |
2004-03-23 |
Kimberly-Clark Worldwide, Inc. |
Absorbent articles incorporating color change graphics
|
|
CA2377771A1
(en)
|
1999-07-01 |
2001-01-11 |
Ajinomoto Co., Inc. |
Heterocyclic compounds and medical use thereof
|
|
WO2001007027A2
(en)
|
1999-07-22 |
2001-02-01 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives for the treatment of viral diseases
|
|
EP1206935A4
(en)
|
1999-07-23 |
2008-07-30 |
Shionogi & Co |
TH2 DIFFERENTIAL INHIBITION
|
|
WO2001007401A1
(en)
|
1999-07-23 |
2001-02-01 |
Shionogi & Co., Ltd. |
Tricyclic compounds and drug compositions containing the same
|
|
IL147913A0
(en)
|
1999-08-12 |
2002-08-14 |
American Cyanamid Co |
Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer
|
|
US6093838A
(en)
|
1999-08-16 |
2000-07-25 |
Allergan Sales, Inc. |
Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
US6127382A
(en)
|
1999-08-16 |
2000-10-03 |
Allergan Sales, Inc. |
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
HUP0202682A3
(en)
|
1999-09-10 |
2003-03-28 |
Merck & Co Inc |
Tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
|
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
|
JP2001089412A
(ja)
|
1999-09-22 |
2001-04-03 |
Otsuka Pharmaceut Co Ltd |
ベンゼン誘導体またはその医薬的に許容される塩
|
|
US6506769B2
(en)
|
1999-10-06 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
WO2001027105A1
(en)
|
1999-10-12 |
2001-04-19 |
Takeda Chemical Industries, Ltd. |
Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
|
|
WO2001032628A1
(en)
|
1999-11-03 |
2001-05-10 |
Bristol-Myers Squibb Pharma Company |
Cyano compounds as factor xa inhibitors
|
|
GB9929988D0
(en)
|
1999-12-17 |
2000-02-09 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
ATE353320T1
(de)
|
1999-12-29 |
2007-02-15 |
Wyeth Corp |
Tricyclische proteinkinasehemmer
|
|
US6638929B2
(en)
|
1999-12-29 |
2003-10-28 |
Wyeth |
Tricyclic protein kinase inhibitors
|
|
US6153752A
(en)
|
2000-01-28 |
2000-11-28 |
Creanova, Inc. |
Process for preparing heterocycles
|
|
JP2003520855A
(ja)
|
2000-01-28 |
2003-07-08 |
アストラゼネカ アクチボラグ |
化学的化合物
|
|
US20020165244A1
(en)
|
2000-01-31 |
2002-11-07 |
Yuhong Zhou |
Mucin synthesis inhibitors
|
|
WO2001060816A1
(en)
|
2000-02-17 |
2001-08-23 |
Amgen Inc. |
Kinase inhibitors
|
|
IL150895A0
(en)
|
2000-02-18 |
2003-02-12 |
Teva Pharma |
Oral, nasal and pulmonary formulations of copolymer-1
|
|
RU2277911C2
(ru)
|
2000-02-25 |
2006-06-20 |
Ф.Хоффманн-Ля Рош Аг |
Модуляторы аденозиновых рецепторов
|
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
WO2001064646A2
(en)
|
2000-03-01 |
2001-09-07 |
Tularik Inc. |
Hydrazones and analogs as cholesterol lowering agents
|
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
ATE414079T1
(de)
|
2000-03-01 |
2008-11-15 |
Janssen Pharmaceutica Nv |
2,4-disubstituierte thiazolyl derivate
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
JP2001247411A
(ja)
|
2000-03-09 |
2001-09-11 |
Tomono Agrica Co Ltd |
有害生物防除剤
|
|
KR20080009294A
(ko)
|
2000-03-13 |
2008-01-28 |
와이어쓰 홀딩스 코포레이션 |
시아노퀴놀린을 포함하는 결장 폴립의 치료 또는 억제를위한 약제학적 조성물
|
|
US6613917B1
(en)
|
2000-03-23 |
2003-09-02 |
Allergan, Inc. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
|
US6608048B2
(en)
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
|
AU2001244614A1
(en)
|
2000-04-04 |
2001-10-15 |
Shionogi & Co., Ltd. |
Oily compositions containing highly fat-soluble drugs
|
|
WO2001076582A1
(fr)
|
2000-04-05 |
2001-10-18 |
Shionogi & Co., Ltd. |
Micro-emulsions huile dans eau contenant des composes tricycliques ou des preconcentres de ceux-ci
|
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
|
DE10024622A1
(de)
|
2000-05-18 |
2001-11-22 |
Piesteritz Stickstoff |
N-(2-Pyrimidinyl)(thio)phosphorsäuretriamide, Verfahren zu ihrer Herstellung und deren Verwendung als Mittel zur Regulierung bzw. Hemmung der enzymatischen Harnstoff-Hydrolyse
|
|
EP1170353B1
(en)
|
2000-07-06 |
2005-11-02 |
Fuji Photo Film Co., Ltd. |
Liquid crystal composition comprising liquid crystal molecules and aligment promoter
|
|
DE60132702T2
(de)
|
2000-08-11 |
2009-03-19 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Heterozyklische verbindungen als inhibitoren von tyrosin-kinasen
|
|
US6638926B2
(en)
|
2000-09-15 |
2003-10-28 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
WO2002030358A2
(en)
|
2000-10-11 |
2002-04-18 |
Tularik Inc. |
Modulation of ccr4 function
|
|
WO2002044166A1
(en)
|
2000-11-02 |
2002-06-06 |
Astrazeneca Ab |
Substituted quinolines as antitumor agents
|
|
AU2001295791A1
(en)
|
2000-11-02 |
2002-05-15 |
Astrazeneca Ab |
4-substituted quinolines as antitumor agents
|
|
WO2002042272A2
(en)
|
2000-11-20 |
2002-05-30 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
|
|
US20070026433A1
(en)
*
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
|
WO2002053101A2
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications
|
|
WO2002053160A1
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating glaucoma ivb
|
|
JP2002221770A
(ja)
|
2001-01-24 |
2002-08-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料およびその処理方法
|
|
US20030130264A1
(en)
|
2001-02-16 |
2003-07-10 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
|
UA75392C2
(en)
|
2001-02-23 |
2006-04-17 |
Merck & Co Inc |
N-substituted non-aryl heterocyclic antagonists nmda/nr2b
|
|
JP2004525139A
(ja)
|
2001-03-23 |
2004-08-19 |
中外製薬株式会社 |
Ｆｌｔ−１リガンド、および血管形成により調節可能な疾患の治療におけるそれらの使用
|
|
EP1389206B1
(en)
|
2001-04-13 |
2006-09-13 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
|
EP1383760A1
(en)
|
2001-04-30 |
2004-01-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Biarylcarboxamide compounds as apolipoprotein b inhibitors
|
|
MXPA03010269A
(es)
|
2001-05-11 |
2004-05-05 |
Vertex Pharma |
Derivados de 2,5-disubstituida piridina, pirimidina, piridazina y 1,2,4-triazina para usarse como inhibidores de p38.
|
|
WO2002094766A1
(en)
|
2001-05-18 |
2002-11-28 |
Nihon Nohyaku Co., Ltd. |
Phthalamide derivative, agricultural or horticultural insecticide, and use thereof
|
|
WO2002096903A2
(fr)
|
2001-05-28 |
2002-12-05 |
Aventis Pharma S.A. |
Derives chimiques et leur application comme agent antitelomerase
|
|
CA2449118A1
(en)
|
2001-05-29 |
2002-12-05 |
Schering Aktiengesellschaft |
Cdk inhibiting pyrimidines, production thereof and their use as medicaments
|
|
CN100384480C
(zh)
|
2001-05-30 |
2008-04-30 |
斯克里普斯研究学院 |
核酸传递系统
|
|
WO2002096905A1
(en)
|
2001-06-01 |
2002-12-05 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinases
|
|
US6689778B2
(en)
|
2001-07-03 |
2004-02-10 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of Src and Lck protein kinases
|
|
US6861529B2
(en)
|
2001-07-06 |
2005-03-01 |
Pfizer Inc |
Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
|
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
|
MXPA04002397A
(es)
|
2001-09-14 |
2004-12-02 |
Methylgene Inc |
Inhibidores de histona deacetilasa.
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
DE10150615A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte
|
|
DE10150610A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Amidbasen
|
|
DE10150614A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Halogen-Metall-Austauschreaktionen
|
|
EP1453516A2
(de)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
NZ531853A
(en)
|
2001-11-01 |
2006-02-24 |
Janssen Pharmaceutica Nv |
Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
|
|
US7183288B2
(en)
|
2001-11-01 |
2007-02-27 |
Herwig Josephus Margareta Janssen, legal representative |
Amide derivatives as glycogen synthase kinase 3-β inhibitors
|
|
US6821988B2
(en)
|
2001-11-27 |
2004-11-23 |
Wyeth Holdings Corporation |
3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
|
|
US20050038035A1
(en)
|
2001-11-28 |
2005-02-17 |
Hisashi Takasugi |
Heterocyclic amide compounds as apolipoprotein b inhibitors
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
US20030166932A1
(en)
|
2002-01-04 |
2003-09-04 |
Beard Richard L. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
AU2003206397B2
(en)
|
2002-01-04 |
2008-07-17 |
The Rockefeller University |
Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
DE60332915D1
(de)
|
2002-02-05 |
2010-07-22 |
Wyeth Llc |
Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren
|
|
CA2476281A1
(en)
|
2002-02-08 |
2003-08-14 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
|
AU2003220970A1
(en)
|
2002-03-01 |
2003-09-16 |
Smithkline Beecham Corporation |
Diamino-pyrimidines and their use as angiogenesis inhibitors
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
AU2003231231A1
(en)
|
2002-05-06 |
2003-11-11 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
WO2004005418A2
(en)
|
2002-07-02 |
2004-01-15 |
Kimberly-Clark Worldwide, Inc. |
Elastomeric adhesive compositions and laminates
|
|
JP4570955B2
(ja)
|
2002-07-09 |
2010-10-27 |
バーテクス ファーマスーティカルズ インコーポレイテッド |
プロテインキナーゼ阻害活性を持つイミダゾール類
|
|
IL166241A0
(en)
|
2002-07-29 |
2006-01-15 |
Rigel Pharmaceuticals Inc |
Method of treating or preventing autoimmune diseases with 2,4-pyrimidinedinediamine compounds
|
|
MXPA05001277A
(es)
|
2002-08-02 |
2005-10-06 |
Ab Science |
2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
|
|
MXPA05001804A
(es)
|
2002-08-14 |
2005-05-27 |
Vertex Pharma |
Inhibidores de proteinas cinasas y usos de los mismos.
|
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
|
DE10240262A1
(de)
|
2002-08-31 |
2004-03-11 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Aryllithium-Basen
|
|
DE10240261A1
(de)
|
2002-08-31 |
2004-03-11 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Halogen-Metall-Austauschreaktionen
|
|
US20050282814A1
(en)
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
EP1549614A4
(en)
|
2002-10-03 |
2008-04-16 |
Targegen Inc |
VASCULATORY AGENTS AND METHODS FOR THEIR APPLICATION
|
|
WO2004032709A2
(en)
|
2002-10-04 |
2004-04-22 |
Caritas St.Elisabeth's Medical Center Of Boston, Inc. |
Inhibition of src for treatment of reperfusion injury related to revascularization
|
|
WO2004037176A2
(en)
|
2002-10-21 |
2004-05-06 |
Bristol-Myers Squibb Company |
Quinazolinones and derivatives thereof as factor xa inhibitors
|
|
AU2003286711A1
(en)
|
2002-10-25 |
2004-05-13 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
ATE371656T1
(de)
|
2002-11-04 |
2007-09-15 |
Vertex Pharma |
Heteroaryl-pyrimidinderivate als jak-inhibitoren
|
|
US8034831B2
(en)
*
|
2002-11-06 |
2011-10-11 |
Celgene Corporation |
Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
|
|
US20050101576A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Novacea, Inc. |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
|
|
JP2006510661A
(ja)
|
2002-12-06 |
2006-03-30 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
Ｐｉ３ｋの阻害剤としてのベンズオキサジン−３−オン類及びその誘導体
|
|
WO2004054186A1
(ja)
|
2002-12-12 |
2004-06-24 |
Fujitsu Limited |
データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
|
|
JP2006518333A
(ja)
|
2002-12-20 |
2006-08-10 |
ファルマシア・コーポレーション |
インテグリン受容体アンタゴニストとしてのヘテロアリールアルカン酸
|
|
BR0317487A
(pt)
|
2002-12-20 |
2005-11-29 |
Pharmacia Corp |
O r-isÈmero de compostos de aminoácido beta como derivados de antagonistas de receptores de integrina
|
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
ES2314271T3
(es)
|
2002-12-24 |
2009-03-16 |
Astrazeneca Ab |
Derivados de quinazolina terapeuticos.
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
CA2513527C
(en)
|
2003-02-07 |
2012-08-14 |
Janssen Pharmaceutica N.V. |
Pyrimidine derivatives for the prevention of hiv infection
|
|
WO2004074266A1
(en)
|
2003-02-07 |
2004-09-02 |
Janssen Pharmaceutica N.V. |
Hiv inhibiting 1,2,4-triazines
|
|
EP1594512A4
(en)
|
2003-02-11 |
2007-07-11 |
Kemia Inc |
COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS
|
|
CL2004000303A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
US20050019395A1
(en)
|
2003-04-14 |
2005-01-27 |
Gabor Pragai |
Formulations of amlodipine maleate
|
|
US20040265375A1
(en)
|
2003-04-16 |
2004-12-30 |
Platteeuw Johannes J. |
Orally disintegrating tablets
|
|
US20040214914A1
(en)
|
2003-04-24 |
2004-10-28 |
Ocular Sciences, Inc. |
Hydrogel contact lenses and package systems and production methods for same
|
|
US8178671B2
(en)
|
2003-07-30 |
2012-05-15 |
Rigel Pharmaceuticals, Inc. |
Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
|
|
PT2287156E
(pt)
|
2003-08-15 |
2013-08-26 |
Novartis Ag |
2,4-di(fenilamino)-pirimidinas úteis no tratamento de doenças neoplásicas, desordens inflamatórias e do sistema imunitário
|
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
|
CA2538413A1
(en)
|
2003-09-18 |
2005-03-24 |
Novartis Ag |
2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
|
EP2543376A1
(en)
|
2004-04-08 |
2013-01-09 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
|
PL382308A1
(pl)
|
2004-08-25 |
2007-08-20 |
Targegen, Inc. |
Związki heterocykliczne i sposoby stosowania
|
|
US7210697B2
(en)
|
2004-12-16 |
2007-05-01 |
Tricam International, Inc. |
Convertible handle
|
|
WO2006074057A2
(en)
|
2004-12-30 |
2006-07-13 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
|
GT200600008A
(es)
*
|
2005-01-18 |
2006-08-09 |
|
Formulacion de compresion directa y proceso
|
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
MX2007011500A
(es)
|
2005-03-16 |
2007-11-21 |
Targegen Inc |
Compuestos pirimidina y metodos de uso.
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
|
JP2008543775A
(ja)
|
2005-06-08 |
2008-12-04 |
ターゲジェン インコーポレーティッド |
眼の障害を治療するための方法および組成物
|
|
CN105348203B
(zh)
|
2005-06-08 |
2018-09-18 |
里格尔药品股份有限公司 |
抑制jak途径的组合物和方法
|
|
KR100848205B1
(ko)
|
2005-06-20 |
2008-07-24 |
주식회사 동부하이텍 |
면역 억제 및 염증 억제 활성을 갖는 신규한 치환된1,3-티아졸 유도체 또는 이의 약학적으로 허용가능한 염,중간체 화합물 또는 이의 약학적으로 허용가능한 염, 이의제조방법, 및 이를 포함하는 약학적 조성물
|
|
BRPI0612594A2
(pt)
*
|
2005-06-29 |
2010-11-23 |
Panacea Biotec Ltd |
composições farmacêuticas de liberação modificada e processo de pereparação das mesmas
|
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
EP2270014A1
(en)
|
2005-09-22 |
2011-01-05 |
Incyte Corporation |
Azepine inhibitors of janus kinases
|
|
US20070072682A1
(en)
|
2005-09-29 |
2007-03-29 |
Crawford James T Iii |
Head to head electronic poker game assembly and method of operation
|
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
UA109411C2
(uk)
*
|
2005-11-01 |
2015-08-25 |
|
N-трет-бутил-3-(2-хлор-5-метилпіримідин-4-іламіно)бензолсульфонамід та його застосування в способі одержання сполуки
|
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
DK1951684T3
(en)
|
2005-11-01 |
2016-10-24 |
Targegen Inc |
BIARYLMETAPYRIMIDIN kinase inhibitors
|
|
WO2007056023A2
(en)
|
2005-11-02 |
2007-05-18 |
Targegen, Inc. |
Thiazole inhibitors targeting resistant kinase mutations
|
|
JP2009519218A
(ja)
|
2005-11-03 |
2009-05-14 |
エスジーエックス ファーマシューティカルズ、インコーポレイテッド |
ピリミジニル−チオフェンキナーゼモジュレータ
|
|
EP1954256A2
(en)
|
2005-11-09 |
2008-08-13 |
Torrent Pharmaceuticals Ltd |
Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
|
|
PH12012501003B1
(en)
|
2005-11-16 |
2018-04-06 |
Cti Biopharma Corp |
Oxygen linked pyrimidine derivatives
|
|
DK3184526T3
(en)
|
2005-12-13 |
2019-01-14 |
Incyte Holdings Corp |
PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR
|
|
WO2007089768A2
(en)
*
|
2006-01-30 |
2007-08-09 |
Exelixis, Inc. |
4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
|
|
US8962643B2
(en)
|
2006-02-24 |
2015-02-24 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
|
MX2008012514A
(es)
|
2006-04-04 |
2009-02-10 |
Cogentus Pharmaceuticals Inc |
Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de acido.
|
|
WO2007127366A2
(en)
|
2006-04-25 |
2007-11-08 |
Targegen, Inc. |
Kinase inhibitors and methods of use thereof
|
|
JP2009537538A
(ja)
*
|
2006-05-15 |
2009-10-29 |
アカドイア プハルマセウチカルス インコーポレーテッド |
ピマバンセリン医薬製剤
|
|
US8030487B2
(en)
|
2006-07-07 |
2011-10-04 |
Targegen, Inc. |
2-amino—5-substituted pyrimidine inhibitors
|
|
EP2046759A1
(en)
|
2006-07-21 |
2009-04-15 |
Novartis AG |
2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors
|
|
US20080021013A1
(en)
|
2006-07-21 |
2008-01-24 |
Cephalon, Inc. |
JAK inhibitors for treatment of myeloproliferative disorders
|
|
US20110243853A1
(en)
*
|
2006-10-25 |
2011-10-06 |
Jamieson Catriona Helen M |
Models of erythropoiesis
|
|
EP2740731B1
(en)
|
2007-06-13 |
2016-03-23 |
Incyte Holdings Corporation |
Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
DE102007034947B4
(de)
*
|
2007-07-26 |
2009-06-18 |
Siemens Ag |
Vorrichtung zum Entladen eines Stapels von auf ihren Schmalseiten stehenden flachen Gegenständen
|
|
CN101802182A
(zh)
*
|
2007-08-21 |
2010-08-11 |
诺达利蒂公司 |
用于诊断、预后和治疗方法的方法
|
|
WO2009046416A1
(en)
|
2007-10-05 |
2009-04-09 |
Targegen Inc. |
Anilinopyrimidines as jak kinase inhibitors
|
|
US20100310563A1
(en)
|
2007-11-30 |
2010-12-09 |
Bumm Thomas G P |
Methods for treating induced cellular proliferative disorders
|
|
EP2296632A4
(en)
*
|
2008-07-14 |
2014-11-12 |
Otonomy Inc |
COMPOSITIONS AND METHODS FOR MODULATING CONTROLLED RELEASE APOPTOSIS FOR THE TREATMENT OF OTIC DISORDERS
|
|
CN102112131A
(zh)
|
2008-08-05 |
2011-06-29 |
塔格根公司 |
治疗地中海贫血的方法
|
|
US8987243B2
(en)
|
2008-12-11 |
2015-03-24 |
Cti Biopharma Corp. |
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate salt
|
|
PL2229938T3
(pl)
|
2009-03-13 |
2012-09-28 |
Sanovel Ilac Sanayi Ve Ticaret As |
Kompozycje ezetymibu
|
|
US20100278921A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Fischer Cristina M |
Solid oral formulation of abt-263
|
|
US20100297194A1
(en)
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
|
US20120190806A1
(en)
|
2009-07-31 |
2012-07-26 |
Basf Se |
Phosphine Borane Compounds Comprising Imidazol Groups And Method For Producing Phosphine Borane Compounds Comprising Imidazol Groups
|
|
EP2470534A4
(en)
|
2009-08-24 |
2013-02-27 |
Merck Sharp & Dohme |
JAK INHIBITION FOR BLOCKING TOXICITY ASSOCIATED WITH RNA INTERFERENCE
|
|
AU2010363329A1
(en)
|
2010-11-07 |
2013-05-09 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
TW201316989A
(zh)
|
2011-07-21 |
2013-05-01 |
Sanofi Sa |
用於治療真性多血症及原發性血小板過多症之組合物及方法
|
|
WO2013059548A1
(en)
|
2011-10-19 |
2013-04-25 |
Sanofi |
Compositions and methods for treating cancer using jak2 inhibitor
|